Original Research

A US Retrospective Claims Analysis Comparing Healthcare Costs of Patients Transitioning from Immediate-Release Oxycodone to Two Different Formulations of Extended-Release Oxycodone: Xtampza ER or OxyContin

Olatoke O, Zah V, Stanicic F, Vukicevic D, Yfantopoulos P, Thompson C, DeGeorge MK, Passik S

ClinicoEconomics and Outcomes Research 2022, 14:119-128

Published Date: 3 March 2022